logo

Astrazeneca Plc (AZN)



Trade AZN now with
  Date
  Headline
2/14/2020 2:01:52 AM AstraZeneca Q4 Reported EPS $0.24; Core EPS $0.89
1/27/2020 2:07:43 AM AstraZeneca: Phase II DESTINY-Gastric01 Trial Of Enhertu Vs Chemotherapy Met Primary Endpoint
1/27/2020 2:05:54 AM AstraZeneca Sells Inderal, Tenormin, Tenoretic, Zestril And Zestoretic To Atnahs
1/27/2020 2:04:33 AM AstraZeneca: Brilinta Met Primary Endpoint In Phase III THALES Trial In Stroke
1/27/2020 1:17:00 AM Allergan Enters Definitive Agreements To Divest Brazikumab And Zenpep
1/20/2020 2:05:46 AM AstraZeneca: Lynparza Regulatory Submission Granted Priority Review In US
1/20/2020 2:04:39 AM AstraZeneca: Imfinzi And Tremelimumab Granted Orphan Drug Designation In US
1/13/2020 2:05:56 AM AstraZeneca Provides Update On Phase III STRENGTH Trial For Epanova In Mixed Dyslipidaemia
1/13/2020 2:05:21 AM AstraZeneca Says SNDA For Lynparza In Combination With Bevacizumab Accepted And Granted Priority Review In The US
1/6/2020 2:09:23 AM AstraZeneca: FDA Accept SNDA And Granted Priority Review For Farxiga
1/6/2020 2:08:22 AM AstraZeneca Says Lokelma Approved In China For Adult Patients With Hyperkalaemia
  
 
>